Cargando…

Occurrence of Hepatocellular Carcinoma in a 40-Year-Old Male With MEN2A Syndrome

Background: Multiple Endocrine Neoplasia Type 2A (MEN 2A) is a genetic syndrome in which the patient is susceptible to the development of: 1. medullary thyroid carcinoma, 2. pheochromocytoma, and 3. parathyroid adenomas or hyperplasia. Our objective is to report the first occurrence of hepatocellula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kontoghiorghes, Christopher P, Lovre, Dragana, Galagan, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089189/ http://dx.doi.org/10.1210/jendso/bvab048.2051

Ejemplares similares

SAT-310 (18)F-FDOPA PET/CT Accurately Identifies Pheochromocytoma in 70-Year-Old Male with MEN1
por: Tepede, Aisha, et al.
Publicado: (2019)

SAT-LB310 A Mysterious Multiple Endocrine Neoplasia (MEN) Like Syndrome
por: Soe, Myat Han, et al.
Publicado: (2020)

MON-912 Undiagnosed Chronic Eczema as a Presentation of Glucagonoma in MEN 1 Syndrome
por: Dejhansathit, Siroj, et al.
Publicado: (2020)

Simultaneous Occurrence of Germline Pathogenic Allele Variants of TMEM127 and TP53 in a Brazilian Family With Li-Fraumeni Syndrome
por: Lima, Jose Viana, et al.
Publicado: (2021)

SAT-LB302 From Urolithiasis to Genetic Testing: An Unusual Presentation of MEN-4 Syndrome
por: Alamri, Bader Nasser, et al.
Publicado: (2020)

MON-328 Twenty-Year Follow-Up of a Patient with a Novel MEN1 Gene Mutation
por: Mao, Yuanjie, et al.
Publicado: (2019)

MON-901 Primary Amenorrhea, Growth Arrest and Metabolic Syndrome Due to an Unclassified Hepatocellular Adenoma
por: Huang, Zhimin, et al.
Publicado: (2020)

THU534 Humoral Hypercalcemia Of Malignancy As Initial Presentation Of Hepatocellular Carcinoma And Monoclonal Gammopathy Of Undetermined Significance
por: Jovanovic, Filip, et al.
Publicado: (2023)

MON-320 Lost in the Rugae: High Grade Gastric Neuroendocrine Tumor in an MEN1 Patient with Zollinger-Ellison Syndrome
por: Bansal, Rashika, et al.
Publicado: (2019)

THU497 Elucidating The Role Of The IQGAP1-YAP Axis In ECM Stiffness-Mediated Hepatocellular Carcinoma Progression
por: Hobbs, Steven E, et al.
Publicado: (2023)

SAT-324 An Unusual Association between Pheochromocytoma and Hyperparathyroidism in a Patient with Neurofibromatosis Type 1: A Possible Co-Occurrence of Two Hereditary Endocrine Tumor Syndromes
por: Kiatpanabhikul, Phatharaporn, et al.
Publicado: (2019)

Hypercalcemia in Pheochromocytoma: From MEN to VHL
por: Mittal, Madhukar, et al.
Publicado: (2021)

MON-314 Insulin-like Growth Factor 2 Drives Hepatocellular Carcinoma In Hepatocyte Srsf3 Ko Mice
por: Kumar, Deepak, et al.
Publicado: (2019)

RF07 | PSUN384 Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma
por: Das, Manasi, et al.
Publicado: (2022)

SAT-321 Bilateral Cortical Sparing Adrenalectomy For Treatment Of Pheochromocytoma In A MEN2-a Mutation Carrier: 19 Year Follow-up
por: de Almeida, Tobias, et al.
Publicado: (2019)

SUN-913 A MEN-2a Syndrome Index Case Presenting with Adrenergic Crisis and Cardiogenic Shock Due to Bilateral Pheochromocytoma
por: Salazar, Daniela, et al.
Publicado: (2020)

SAT-LB054 Growth Hormone Receptor (GHR) Antagonism Suppresses Hepatocellular Carcinoma Growth in a Syngeneic Mouse Model
por: Mathes, Samuel, et al.
Publicado: (2019)

MON-325 Co-Occurrence of Breast Cancer and Neuroendocrine Tumors: More Than a Coincidence?
por: Larouche, Vincent, et al.
Publicado: (2019)

SAT-117 Refractory Paraneoplastic Non Islet Cell Tumor Hypoglycemia (NICTH) from Hepatocellular Carcinoma Managed with Somatostatin Analogue and Glucocorticoids
por: Siddiqui, Mahwash Fatima, et al.
Publicado: (2020)

Development of Delayed Paraneoplastic ACTH Syndrome in Small Cell Lung Carcinoma
por: Azmath, Misbah, et al.
Publicado: (2021)

SUN-917 Aggressive De Novo MEN1 Variant in a Child with Metastatic Pancreatic Acth and Crh Co-Secreting Neuroendocrine Tumor: Diagnosis and 10-Year Follow Up
por: Bompou, Maria Eleni, et al.
Publicado: (2020)

SUN-124 Are Venous Thromboembolic Events Increased in MEN1 Patients?
por: Lee, Maya E, et al.
Publicado: (2020)

Surgical Management of Large Gastrinomas in a Young Patient With MEN1
por: Burgos, Nydia, et al.
Publicado: (2021)

MON-330 Cushing Syndrome Secondary to Neuroendocrine Lung Carcinoma: To X-Ray or Not to X-Ray?
por: Zainal, Abir, et al.
Publicado: (2019)

Recurrent Cushing Syndrome Secondary to Metastatic Adrenocortical Carcinoma in a Patient With Previously Resected Adenoma
por: Addasi, Noor, et al.
Publicado: (2021)

SUN-909 A Unique Presentation of Multiple Endocrine Neoplasia (MEN) Type 1 Mosaicism Caused by a Novel c.124G>A Variant in the MEN1 Gene
por: Drummond, Russell Sinclair, et al.
Publicado: (2020)

MON-323 Metastatic Adrenocortical Carcinoma Presenting with Mixed Cushing's and Virilization Syndrome along with Bilateral Pulmonary Emboli
por: Parham, Johnathon, et al.
Publicado: (2019)

SUN-319 Failure Of Pasireotide To Control Hypoglycemia In A Men-1 Patient With Metastatic Insulinoma
por: de Almeida, Tobias, et al.
Publicado: (2019)

SUN-912 The Rare Men of Mississippi Complications in the Diagnosis of Multiple Endocrine Neoplasia Type 1
por: Rashid, Hytham, et al.
Publicado: (2020)

Metastatic Insulinoma Presenting After Bariatric Surgery in a Patient Subsequently Diagnosed With MEN 1
por: Poku, Caroline A, et al.
Publicado: (2021)

Calcitonin Changed During Pregnancy in MEN2A With MTC Patient: A Case Report
por: Porntharukchareon, Thachanun, et al.
Publicado: (2021)

SAT-272 Pituitary Macroadenoma Co-Secreting TSH and PRL Responsive to Cabergoline
por: Tirumalasetty, Saritha, et al.
Publicado: (2020)

PMON129 Pituitary Adenoma Co-Secreting GH, Prolactin and ACTH
por: Wilson, Sarah, et al.
Publicado: (2022)

MON-LB059 A Family Reunion at the Geneticist's Office: Hypercalcemia as Presenting Symptoms of MEN1
por: Park, Jun, et al.
Publicado: (2019)

SUN-331 Clinical Characteristics and Genotype-Phenotype Analysis of MEN1 Patients with Thymic Neuroendocrine Tumors
por: Mandl, Adel, et al.
Publicado: (2019)

Systemic Immune Response in Murine Bilateral Pheochromocytoma Model During Immunotherapy Based on a Combination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibodies (MBTA Therapy)
por: Uher, Ondrej, et al.
Publicado: (2021)

THU522 Symptomatic Hypoglycemia As The First Manifestation Of Multiple Endocrine Neoplasia Type 1 (MEN-1): Case Report
por: Oliveira, Vitória Dupas, et al.
Publicado: (2023)

THU511 Somatostatin Analogs Or Active Surveillance In Sporadic And MEN1 Associated Non-functioning Pancreatic Neuroendocrine Tumors
por: Raia, Salvatore, et al.
Publicado: (2023)

SAT-LB308 Primary Hyperparathyroidism and Meningioma as a Part of Multiple Endocrine Neoplasm Type 1 (MEN Type 1)
por: ElEbrashy, Shady Ibrahim, et al.
Publicado: (2020)

MON-916 Pure Large Cell Neuroendocrine Carcinoma (LCNEC) of the Gall Bladder in a Patient with Down Syndrome - a Rare Case of an Aggressive Tumor of the Gall Bladder
por: Azmath, Misbah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ktvt2tubgvhr32uiph4dksa7n7